Acute vitamin B12 supplementation evokes antidepressant response and alters Ntrk-2.
Animals
Antidepressive Agents
/ pharmacology
Behavior, Animal
CRISPR-Cas Systems
Cell Line
DNA Methylation
/ drug effects
Depression
/ drug therapy
Epigenomics
Female
Gene Expression
/ drug effects
Male
Membrane Glycoproteins
/ antagonists & inhibitors
Mice
Mice, Inbred C57BL
Prefrontal Cortex
/ drug effects
Protein-Tyrosine Kinases
/ antagonists & inhibitors
Receptor, trkB
/ drug effects
Vitamin B 12
/ pharmacology
Antidepressant
DNA methylation
Depression
Ntrk-2
TrkB
Vitamin B12
Journal
Neuropharmacology
ISSN: 1873-7064
Titre abrégé: Neuropharmacology
Pays: England
ID NLM: 0236217
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
received:
04
12
2019
revised:
15
04
2020
accepted:
17
04
2020
pubmed:
27
4
2020
medline:
29
6
2021
entrez:
27
4
2020
Statut:
ppublish
Résumé
Depression is the leading cause of disability worldwide. Although most research into risk factors focuses on stress, dietary factors also have a strong link with depression. For instance, chronic vitamin B12-supplementation may reduce depression risk and helps to reverse the prodepressive effects of early life stress in animal models. However, it is still unclear whether a single acute dose of vitamin B12 is sufficient to induce antidepressant effects on molecular or behavioral levels. Based on pharmacological work and CRISPR-dCas9 epigenome editing in Neuro2A-cells we provide in vitro evidence for a link between vitamin B12, gene expression and DNA methylation of the antidepressant-associated gene Ntrk-2, which codes for the BDNF-receptor TRKB. Using stress-induction protocols in C57Bl/6 J mice combined with behavioral testing and subsequent molecular tissue analysis, we establish in vivo evidence for antidepressant effects of vitamin B12. Acute supplementation with vitamin B12, but not folic acid, selectively altered DNA methylation and gene expression of Ntrk-2 in vitro, albeit DNA methylation and Ntrk-2 gene expression do not correlate in vivo. Importantly, one acute vitamin B12 injection improved multiple behavioral measures in tests for antidepressant action and at the same time reversed the effects of chronic and acute stress on Ntrk-2 levels in vivo, however causality has not been proven at this stage. Taken together, acute vitamin B12 supplementation can reverse stress effects on Ntrk-2 gene expression and improve behaviors that are associated with depression-like behavior in mice. Our findings encourage further investigation of vitamin B12-supplementation as a novel model for antidepressant action.
Identifiants
pubmed: 32335151
pii: S0028-3908(20)30180-5
doi: 10.1016/j.neuropharm.2020.108112
pii:
doi:
Substances chimiques
Antidepressive Agents
0
Membrane Glycoproteins
0
Ntrk2 protein, mouse
EC 2.7.10.1
Protein-Tyrosine Kinases
EC 2.7.10.1
Receptor, trkB
EC 2.7.10.1
Vitamin B 12
P6YC3EG204
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
108112Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors have no competing interests to declare or interests to disclose.